Wong KK - Search Results

1

Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis.

Allen SG, Rosen BS, Aryal M, Cao Y, Schipper MJ, Wong KK, Casper KA, Chinn SB, Malloy KM, Prince ME, Rosko AJ, Shuman AG, Spector ME, Stucken CL, Swiecicki PL, Worden FP, Brenner JC, Schonewolf CA, Elliott DA, Mierzwa ML, Shah JL. Allen SG, et al. Among authors: wong kk. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):171-180. doi: 10.1016/j.ijrobp.2023.03.043. Epub 2023 Mar 16. Int J Radiat Oncol Biol Phys. 2023. PMID: 36931572 Clinical Trial.

2

Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.

Vainshtein JM, Spector ME, Stenmark MH, Bradford CR, Wolf GT, Worden FP, Chepeha DB, McHugh JB, Carey T, Wong KK, Eisbruch A. Vainshtein JM, et al. Among authors: wong kk. Oral Oncol. 2014 Mar;50(3):234-9. doi: 10.1016/j.oraloncology.2013.12.003. Epub 2013 Dec 31. Oral Oncol. 2014. PMID: 24387978 Free PMC article.

3

Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.

Vainshtein JM, Spector ME, McHugh JB, Wong KK, Walline HM, Byrd SA, Komarck CM, Ibrahim M, Stenmark MH, Prince ME, Bradford CR, Wolf GT, McLean S, Worden FP, Chepeha DB, Carey T, Eisbruch A. Vainshtein JM, et al. Among authors: wong kk. Oral Oncol. 2014 May;50(5):513-9. doi: 10.1016/j.oraloncology.2014.02.001. Epub 2014 Feb 22. Oral Oncol. 2014. PMID: 24565983 Free PMC article.

4

Metabolic response assessment with ¹⁸F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancer.

Wang J, Wong KK, Piert M, Stanton P, Frey KA, Kong FS. Wang J, et al. Among authors: wong kk. J Radiat Oncol. 2015;4(3):249-256. doi: 10.1007/s13566-015-0184-9. Epub 2015 Mar 12. J Radiat Oncol. 2015. PMID: 26366253 Free PMC article.

5

Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.

Rosko A, Birkeland A, Shuman A, Prince M, Bradford C, Wolf G, Worden F, Eisbruch A, Srinivasan A, Wong KK, Spector ME. Rosko A, et al. Among authors: wong kk. Head Neck. 2017 May;39(5):980-987. doi: 10.1002/hed.24719. Epub 2017 Feb 25. Head Neck. 2017. PMID: 28236331 Free PMC article.

6

A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After ¹⁷⁷Lu-DOTATATE.

Devasia TP, Dewaraja YK, Frey KA, Wong KK, Schipper MJ. Devasia TP, et al. Among authors: wong kk. J Nucl Med. 2021 Aug 1;62(8):1118-1125. doi: 10.2967/jnumed.120.256255. Epub 2020 Dec 18. J Nucl Med. 2021. PMID: 33443063 Free PMC article.

7

Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumors.

Wong KK, Frey KA, Niedbala J, Kaza RK, Worden FP, Fitzpatrick KJ, Dewaraja YK. Wong KK, et al. Nucl Med Commun. 2022 Aug 1;43(8):892-900. doi: 10.1097/MNM.0000000000001592. Epub 2022 Jun 10. Nucl Med Commun. 2022. PMID: 35703269 Free PMC article.

8

177Lu-DOTATATE Theranostics: Predicting Renal Dosimetry From Pretherapy 68Ga-DOTATATE PET and Clinical Biomarkers.

Peterson AB, Wang C, Wong KK, Frey KA, Muzik O, Schipper MJ, Dewaraja YK. Peterson AB, et al. Among authors: wong kk. Clin Nucl Med. 2023 May 1;48(5):393-399. doi: 10.1097/RLU.0000000000004599. Epub 2023 Feb 8. Clin Nucl Med. 2023. PMID: 37010563 Free PMC article.

9

Single-Time-Point Imaging for Dosimetry After [¹⁷⁷Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection.

Wang C, Peterson AB, Wong KK, Roseland ME, Schipper MJ, Dewaraja YK. Wang C, et al. Among authors: wong kk. J Nucl Med. 2023 Sep;64(9):1463-1470. doi: 10.2967/jnumed.122.265338. Epub 2023 Jul 27. J Nucl Med. 2023. PMID: 37500260 Free PMC article.

10

Inter-method Comparison and Optimization of [18F] FDG PET Metabolic Response Assessment in Non-Small Cell Lung Cancer.

Kong F, Wang J, Wong K, Piert M, Frey K. Kong F, et al. Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S23. doi: 10.1016/j.prro.2013.01.083. Epub 2013 Mar 25. Pract Radiat Oncol. 2013. PMID: 24674521 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,757 results

Search Page